I am obsessed with a Slate advice column called "Dear Prudence." In fact, after I first stumbled upon it, I engaged in a few marathon sessions reading through the archives (not at the office, Liz).
I feel like we’ve heard a lot of HME providers talking about the important role that they play in helping to reduce hospital readmission rates, and I feel like we’ve seen some providers walking the talk, too.
This is Elizabeth Deprey reporting to you live from the first-ever National CRT Leadership and Advocacy Conference. Keep an eye on my tweets for some updates. There was so much info at the first event, an industry panel discussion, Twitter could never do it justice.
The more I think about the mail-order program for diabetes, the more it ticks me off. I mean, every week folks (not just in the diabetes space) come up with all sorts of creative ways to criticize the program or question various technical aspects.
I was talking to an HME provider on the phone yesterday, which I’m known to do, and he mentioned a guest blog that we posted to our website recently in which a provider makes the case for allowing competitive bidding to move forward a
